Literature DB >> 23744135

'Basket studies' will hold intricate data for cancer drug approvals.

Cassandra Willyard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23744135     DOI： 10.1038/nm0613-655

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  28 in total

Review 1.  [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].

Authors:  F Klauschen
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  Reading between the lines; understanding drug response in the post genomic era.

Authors:  Constantine C Alifrangis; Ultan McDermott
Journal:  Mol Oncol       Date:  2014-06-10       Impact factor: 6.603

3.  How "precise" is precision medicine in hematology?

Authors:  Carlo Gambacorti-Passerini; Rocco Piazza
Journal:  Haematologica       Date:  2017-01       Impact factor: 9.941

4.  Adaptive clinical trial designs in oncology.

Authors:  Yong Zang; J Jack Lee
Journal:  Chin Clin Oncol       Date:  2014-12

Review 5.  Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.

Authors:  Senthilkumar Damodaran; Michael F Berger; Sameek Roychowdhury
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

Review 6.  Next-Generation Sequencing to Guide Clinical Trials.

Authors:  Lillian L Siu; Barbara A Conley; Scott Boerner; Patricia M LoRusso
Journal:  Clin Cancer Res       Date:  2015-10-15       Impact factor: 12.531

7.  The dream and reality of histology agnostic cancer clinical trials.

Authors:  Denis Lacombe; Susen Burock; Jan Bogaerts; Patrick Schoeffski; Vassilis Golfinopoulos; Roger Stupp
Journal:  Mol Oncol       Date:  2014-09-12       Impact factor: 6.603

Review 8.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

Review 9.  Rapid learning for precision oncology.

Authors:  Jeff Shrager; Jay M Tenenbaum
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

Review 10.  Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Authors:  Keith T Schmidt; Cindy H Chau; Douglas K Price; William D Figg
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.